XT
LGND icon

XTX Topco’s Ligand Pharmaceuticals LGND Stock Holding History

XTX Topco’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,237
Closed -$247K – 4465
2026
Q1 		$247K Sell
1,237
-6,480
-84% -$1.28M ﹤0.01% 2661
2025
Q4 		$1.46M Buy
+7,717
New +$1.48M 0.04% 763
2025
Q1 		– Sell
-3,067
Closed -$329K – 2767
2024
Q4 		$329K Buy
+3,067
New +$347K 0.03% 1141
2023
Q3 		– Sell
-6,161
Closed -$444K – 1801
2023
Q2 		$444K Buy
6,161
+2,220
+56% +$167K 0.08% 441
2023
Q1 		$290K Buy
+3,941
New +$280K 0.06% 677

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's LGND Position: Q2 2026 in Review

XTX Topco sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 1,237 shares — an estimated $247K sold.

XTX Topco first reported a position in LGND in Q1 2023 and held it in 5 quarters. The position peaked at $1.46M in Q4 2025. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • XTX Topco reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 1,237 Ligand Pharmaceuticals shares in Q2 2026, an estimated $247K.
  • XTX Topco first reported a position in Ligand Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • XTX Topco's Ligand Pharmaceuticals position peaked at $1.46M in Q4 2025.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.